Bolt Biotherapeutics, Inc. (BOLT)
4.91
-0.15
(-2.96%)
USD |
NASDAQ |
Nov 20, 16:00
4.91
0.00 (0.00%)
After-Hours: 20:00
Bolt Biotherapeutics Gross Profit (TTM) : 1.836M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.836M |
| June 30, 2026 | 3.781M |
| March 31, 2026 | 5.404M |
| December 31, 2025 | 6.404M |
| September 30, 2025 | 3.733M |
| June 30, 2025 | 2.555M |
| March 31, 2025 | 1.916M |
| December 31, 2024 | 5.909M |
| September 30, 2024 | 7.927M |
| June 30, 2024 | 9.292M |
| March 31, 2024 | 8.718M |
| December 31, 2023 | 4.542M |
| September 30, 2023 | 3.194M |
| June 30, 2023 | 2.119M |
| March 31, 2023 | 1.875M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.52M |
| September 30, 2022 | -0.121M |
| June 30, 2022 | -1.112M |
| March 31, 2022 | -2.012M |
| December 31, 2021 | -2.099M |
| September 30, 2021 | -2.464M |
| June 30, 2021 | -3.11M |
| March 31, 2021 | -2.21M |
| December 31, 2020 | -1.408M |
| September 30, 2020 | -0.646M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Caribou Biosciences, Inc. | 6.898M |
| Oncolytics Biotech, Inc. | -0.048M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.074B |
| Anixa Biosciences, Inc. | -0.039M |